Labcorp Holdings Inc.
LH
$268.78
$0.510.19%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 13.77B | 13.48B | 13.18B | 13.01B | 12.71B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 13.77B | 13.48B | 13.18B | 13.01B | 12.71B |
| Cost of Revenue | 9.85B | 9.69B | 9.50B | 9.38B | 9.16B |
| Gross Profit | 3.92B | 3.79B | 3.68B | 3.62B | 3.55B |
| SG&A Expenses | 2.27B | 2.29B | 2.27B | 2.23B | 2.18B |
| Depreciation & Amortization | 277.80M | 272.00M | 265.90M | 256.40M | 245.20M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 12.40B | 12.25B | 12.04B | 11.87B | 11.59B |
| Operating Income | 1.36B | 1.23B | 1.14B | 1.14B | 1.13B |
| Income Before Tax | 1.10B | 974.30M | 937.30M | 959.50M | 628.60M |
| Income Tax Expenses | 244.30M | 209.80M | 205.50M | 212.40M | 191.90M |
| Earnings from Continuing Operations | 856.40 | 764.50 | 731.80 | 747.10 | 436.70 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | 0.00 |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -1.20M | -1.10M | -1.00M | -1.10M | -1.20M |
| Net Income | 855.20M | 763.40M | 730.80M | 746.00M | 435.50M |
| EBIT | 1.36B | 1.23B | 1.14B | 1.14B | 1.13B |
| EBITDA | 1.96B | 1.82B | 1.72B | 1.70B | 1.68B |
| EPS Basic | 10.26 | 9.13 | 8.72 | 8.88 | 5.20 |
| Normalized Basic EPS | 9.00 | 8.14 | 7.68 | 7.81 | 7.89 |
| EPS Diluted | 10.19 | 9.07 | 8.66 | 8.83 | 5.15 |
| Normalized Diluted EPS | 8.93 | 8.09 | 7.64 | 7.77 | 7.86 |
| Average Basic Shares Outstanding | 333.70M | 334.60M | 335.30M | 335.80M | 337.10M |
| Average Diluted Shares Outstanding | 336.10M | 336.80M | 337.20M | 337.60M | 338.30M |
| Dividend Per Share | 2.88 | 2.88 | 2.88 | 2.88 | 2.88 |
| Payout Ratio | 28.24% | 31.71% | 33.20% | 32.59% | 56.05% |